KIMS IPO

Krishna Institute of Medical Sciences Limited IPO

₹14,670 /18 sharesMinimum Investment

KIMS IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
16 Jun ‘21 - 18 Jun ‘21₹14,67018₹815 - ₹825
Issue SizeIPO Doc
2143.74Cr
RHP PDF

Subscription Status As on 18 Jun '21, 4:50 PM

  • Retail Individual Investor
    2.89x
  • Non-Institutional Investor
    1.89x
  • Qualified Institutional Buyers
    5.26x
  • Employees
    1.06x

About KIMS

Krishna Institute of Medical Sciences Ltd. is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of the number of patients treated and treatments offered. It provides multi-disciplinary integrated healthcare services, with a focus on primary, secondary, and tertiary care in Tier 2-3 cities and primary, secondary, tertiary, and quaternary healthcare in Tier 1 cities. KIMS operates nine multi-specialty hospitals under the “KIMS Hospitals” brand, with an aggregate bed capacity of 3,064, including over 2,500 operational beds as of March 31, 2021. This is 2.2 times more beds than the second-largest provider in Andhra Pradesh and Telangana. The range of healthcare services offered is spread across over 25 specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopedics, organ transplantation, renal sciences, and mother & child care;
Parent Organisation
Krishna Institute of Medical Sciences Limited IPO
Founded
1973
Managing Director
Bhaskara Rao Bollineni

Strengths & Risks

  • One of the largest corporate healthcare groups in Telangana and Andhra Pradesh.
  • Well-positioned to consolidate in India’s large, unorganized yet rapidly growing and underserved affordable healthcare market.
  • Ability to attract, train and retain high-quality doctors, consultants, and medical support staff.
  • Track record of strong operational and financial performance.
  • Successful history of sourcing, executing and integrating acquisitions.
  • Experienced senior management team with strong institutional shareholder support.
  • Dependence on its healthcare professionals, including doctors that KIMS engages on a consultancy basis.
  • COVID-19 pandemic and other health concerns that may impact regular business operations.
  • Dependence on hospitals in Hyderabad and certain specialties.
  • Hospitals built on leased land and inability to renew the lease for any reason.
  • Impact of short-term and long-term borrowings.
  • Inability to comply with applicable safety, health, environmental, and other governmental regulations.
  • Inability to effectively estimate, price, and manage its healthcare costs can affect operations.
  • Inability to maintain bed occupancy rates at sufficient levels may impact business.
  • Inability to keep pace with technological changes, new equipment & service introductions, changes in patients' needs, and evolving industry standards.
  • Dependence on payments from patients, insurers, and other payers.
  • Risk of legal claims and regulatory actions arising out of the medical services provided by KIMS.
  • Failure of third-party suppliers and manufacturers to provide supplies and equipment on time.
  • Risks relating to the handling of personal information, including medical data.

Financials

*All values are in Rs. Cr
No Graph Data To Display

Application details

Apply asPrice bandApply upto
For KIMS Hospitals IPO, eligible investors can apply as
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.7.6
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ

ABOUT GROWW